nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Histamine Phosphate—HRH4—stomach cancer	0.0116	0.521	CrCbGaD
Pamidronate—FDPS—hematopoietic system—stomach cancer	0.011	0.161	CbGeAlD
Pamidronate—FDPS—smooth muscle tissue—stomach cancer	0.00968	0.141	CbGeAlD
Pamidronate—FDPS—pancreas—stomach cancer	0.00895	0.131	CbGeAlD
Pamidronate—FDPS—lymphoid tissue—stomach cancer	0.00773	0.113	CbGeAlD
Pamidronate—FDPS—digestive system—stomach cancer	0.00764	0.112	CbGeAlD
Pamidronate—FDPS—bone marrow—stomach cancer	0.00704	0.103	CbGeAlD
Pamidronate—FDPS—endocrine gland—stomach cancer	0.00631	0.0923	CbGeAlD
Pamidronate—FDPS—liver—stomach cancer	0.00569	0.0832	CbGeAlD
Pamidronate—Zoledronate—CA2—stomach cancer	0.00558	0.249	CrCbGaD
Pamidronate—FDPS—lymph node—stomach cancer	0.00436	0.0638	CbGeAlD
Pamidronate—FDPS—Activation of gene expression by SREBF (SREBP)—SREBF2—stomach cancer	0.00352	0.115	CbGpPWpGaD
Pamidronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—SREBF2—stomach cancer	0.00281	0.0918	CbGpPWpGaD
Pamidronate—Risedronate—PTGS2—stomach cancer	0.00272	0.121	CrCbGaD
Pamidronate—FDPS—SREBP signalling—PRKAB1—stomach cancer	0.00268	0.0874	CbGpPWpGaD
Pamidronate—Clodronate—PTGS2—stomach cancer	0.00242	0.108	CrCbGaD
Pamidronate—FDPS—SREBP signalling—SREBF2—stomach cancer	0.00228	0.0743	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—PRKAA1—stomach cancer	0.00203	0.0662	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—RBP4—stomach cancer	0.00196	0.064	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—PPARG—stomach cancer	0.000779	0.0254	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000708	0.0231	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000593	0.0194	CbGpPWpGaD
Pamidronate—Anorexia—Capecitabine—stomach cancer	0.000564	0.000642	CcSEcCtD
Pamidronate—Angiopathy—Methotrexate—stomach cancer	0.000562	0.00064	CcSEcCtD
Pamidronate—Vomiting—Irinotecan—stomach cancer	0.000562	0.00064	CcSEcCtD
Pamidronate—Sinusitis—Doxorubicin—stomach cancer	0.000561	0.000638	CcSEcCtD
Pamidronate—Immune system disorder—Methotrexate—stomach cancer	0.00056	0.000637	CcSEcCtD
Pamidronate—Dizziness—Fluorouracil—stomach cancer	0.00056	0.000637	CcSEcCtD
Pamidronate—Mediastinal disorder—Methotrexate—stomach cancer	0.000559	0.000636	CcSEcCtD
Pamidronate—Agranulocytosis—Doxorubicin—stomach cancer	0.000558	0.000635	CcSEcCtD
Pamidronate—Rash—Irinotecan—stomach cancer	0.000557	0.000634	CcSEcCtD
Pamidronate—Dermatitis—Irinotecan—stomach cancer	0.000557	0.000634	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000557	0.000634	CcSEcCtD
Pamidronate—Chills—Methotrexate—stomach cancer	0.000556	0.000633	CcSEcCtD
Pamidronate—Headache—Irinotecan—stomach cancer	0.000554	0.00063	CcSEcCtD
Pamidronate—Hypotension—Capecitabine—stomach cancer	0.000553	0.000629	CcSEcCtD
Pamidronate—Insomnia—Docetaxel—stomach cancer	0.000553	0.000629	CcSEcCtD
Pamidronate—Paraesthesia—Docetaxel—stomach cancer	0.000549	0.000624	CcSEcCtD
Pamidronate—Alopecia—Methotrexate—stomach cancer	0.000548	0.000623	CcSEcCtD
Pamidronate—Dyspnoea—Docetaxel—stomach cancer	0.000545	0.00062	CcSEcCtD
Pamidronate—Somnolence—Docetaxel—stomach cancer	0.000543	0.000618	CcSEcCtD
Pamidronate—Eye disorder—Epirubicin—stomach cancer	0.000542	0.000617	CcSEcCtD
Pamidronate—Erythema—Methotrexate—stomach cancer	0.00054	0.000614	CcSEcCtD
Pamidronate—Malnutrition—Methotrexate—stomach cancer	0.00054	0.000614	CcSEcCtD
Pamidronate—Haemoglobin—Doxorubicin—stomach cancer	0.000539	0.000614	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000539	0.000613	CcSEcCtD
Pamidronate—Flushing—Epirubicin—stomach cancer	0.000538	0.000613	CcSEcCtD
Pamidronate—Cardiac disorder—Epirubicin—stomach cancer	0.000538	0.000613	CcSEcCtD
Pamidronate—Vomiting—Fluorouracil—stomach cancer	0.000538	0.000613	CcSEcCtD
Pamidronate—Rhinitis—Doxorubicin—stomach cancer	0.000538	0.000612	CcSEcCtD
Pamidronate—Dyspepsia—Docetaxel—stomach cancer	0.000538	0.000612	CcSEcCtD
Pamidronate—Haemorrhage—Doxorubicin—stomach cancer	0.000537	0.000611	CcSEcCtD
Pamidronate—Insomnia—Capecitabine—stomach cancer	0.000535	0.000609	CcSEcCtD
Pamidronate—Rash—Fluorouracil—stomach cancer	0.000534	0.000607	CcSEcCtD
Pamidronate—Dermatitis—Fluorouracil—stomach cancer	0.000533	0.000607	CcSEcCtD
Pamidronate—Paraesthesia—Capecitabine—stomach cancer	0.000531	0.000605	CcSEcCtD
Pamidronate—Decreased appetite—Docetaxel—stomach cancer	0.000531	0.000605	CcSEcCtD
Pamidronate—Headache—Fluorouracil—stomach cancer	0.00053	0.000604	CcSEcCtD
Pamidronate—Urinary tract disorder—Doxorubicin—stomach cancer	0.00053	0.000603	CcSEcCtD
Pamidronate—Dysgeusia—Methotrexate—stomach cancer	0.000528	0.000601	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000527	0.0006	CcSEcCtD
Pamidronate—Connective tissue disorder—Doxorubicin—stomach cancer	0.000527	0.0006	CcSEcCtD
Pamidronate—Dyspnoea—Capecitabine—stomach cancer	0.000527	0.0006	CcSEcCtD
Pamidronate—Fatigue—Docetaxel—stomach cancer	0.000527	0.0006	CcSEcCtD
Pamidronate—Angiopathy—Epirubicin—stomach cancer	0.000526	0.000599	CcSEcCtD
Pamidronate—Urethral disorder—Doxorubicin—stomach cancer	0.000526	0.000599	CcSEcCtD
Pamidronate—Nausea—Irinotecan—stomach cancer	0.000525	0.000598	CcSEcCtD
Pamidronate—Immune system disorder—Epirubicin—stomach cancer	0.000524	0.000596	CcSEcCtD
Pamidronate—Mediastinal disorder—Epirubicin—stomach cancer	0.000523	0.000595	CcSEcCtD
Pamidronate—Pain—Docetaxel—stomach cancer	0.000522	0.000595	CcSEcCtD
Pamidronate—Constipation—Docetaxel—stomach cancer	0.000522	0.000595	CcSEcCtD
Pamidronate—Back pain—Methotrexate—stomach cancer	0.000522	0.000594	CcSEcCtD
Pamidronate—Dyspepsia—Capecitabine—stomach cancer	0.000521	0.000593	CcSEcCtD
Pamidronate—Chills—Epirubicin—stomach cancer	0.00052	0.000592	CcSEcCtD
Pamidronate—Decreased appetite—Capecitabine—stomach cancer	0.000514	0.000585	CcSEcCtD
Pamidronate—Alopecia—Epirubicin—stomach cancer	0.000513	0.000583	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000511	0.000581	CcSEcCtD
Pamidronate—Fatigue—Capecitabine—stomach cancer	0.00051	0.00058	CcSEcCtD
Pamidronate—Pain—Capecitabine—stomach cancer	0.000506	0.000576	CcSEcCtD
Pamidronate—Constipation—Capecitabine—stomach cancer	0.000506	0.000576	CcSEcCtD
Pamidronate—Erythema—Epirubicin—stomach cancer	0.000505	0.000575	CcSEcCtD
Pamidronate—Malnutrition—Epirubicin—stomach cancer	0.000505	0.000575	CcSEcCtD
Pamidronate—Feeling abnormal—Docetaxel—stomach cancer	0.000503	0.000573	CcSEcCtD
Pamidronate—Nausea—Fluorouracil—stomach cancer	0.000503	0.000572	CcSEcCtD
Pamidronate—Eye disorder—Doxorubicin—stomach cancer	0.000502	0.000571	CcSEcCtD
Pamidronate—Ill-defined disorder—Methotrexate—stomach cancer	0.000501	0.00057	CcSEcCtD
Pamidronate—Gastrointestinal pain—Docetaxel—stomach cancer	0.0005	0.000569	CcSEcCtD
Pamidronate—Anaemia—Methotrexate—stomach cancer	0.000499	0.000568	CcSEcCtD
Pamidronate—Flushing—Doxorubicin—stomach cancer	0.000498	0.000567	CcSEcCtD
Pamidronate—Cardiac disorder—Doxorubicin—stomach cancer	0.000498	0.000567	CcSEcCtD
Pamidronate—Tension—Epirubicin—stomach cancer	0.000495	0.000564	CcSEcCtD
Pamidronate—Dysgeusia—Epirubicin—stomach cancer	0.000494	0.000563	CcSEcCtD
Pamidronate—Nervousness—Epirubicin—stomach cancer	0.00049	0.000558	CcSEcCtD
Pamidronate—FDPS—Metabolism—ACAD8—stomach cancer	0.000489	0.016	CbGpPWpGaD
Pamidronate—Back pain—Epirubicin—stomach cancer	0.000488	0.000556	CcSEcCtD
Pamidronate—Feeling abnormal—Capecitabine—stomach cancer	0.000487	0.000555	CcSEcCtD
Pamidronate—Angiopathy—Doxorubicin—stomach cancer	0.000487	0.000554	CcSEcCtD
Pamidronate—Malaise—Methotrexate—stomach cancer	0.000487	0.000554	CcSEcCtD
Pamidronate—Muscle spasms—Epirubicin—stomach cancer	0.000485	0.000553	CcSEcCtD
Pamidronate—Immune system disorder—Doxorubicin—stomach cancer	0.000485	0.000552	CcSEcCtD
Pamidronate—Gastrointestinal pain—Capecitabine—stomach cancer	0.000484	0.000551	CcSEcCtD
Pamidronate—Mediastinal disorder—Doxorubicin—stomach cancer	0.000484	0.000551	CcSEcCtD
Pamidronate—Abdominal pain—Docetaxel—stomach cancer	0.000483	0.00055	CcSEcCtD
Pamidronate—Body temperature increased—Docetaxel—stomach cancer	0.000483	0.00055	CcSEcCtD
Pamidronate—Leukopenia—Methotrexate—stomach cancer	0.000483	0.00055	CcSEcCtD
Pamidronate—Chills—Doxorubicin—stomach cancer	0.000482	0.000548	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000478	0.0156	CbGpPWpGaD
Pamidronate—Alopecia—Doxorubicin—stomach cancer	0.000474	0.00054	CcSEcCtD
Pamidronate—Cough—Methotrexate—stomach cancer	0.000471	0.000536	CcSEcCtD
Pamidronate—Ill-defined disorder—Epirubicin—stomach cancer	0.000469	0.000533	CcSEcCtD
Pamidronate—Body temperature increased—Capecitabine—stomach cancer	0.000468	0.000532	CcSEcCtD
Pamidronate—Abdominal pain—Capecitabine—stomach cancer	0.000468	0.000532	CcSEcCtD
Pamidronate—Convulsion—Methotrexate—stomach cancer	0.000467	0.000532	CcSEcCtD
Pamidronate—Malnutrition—Doxorubicin—stomach cancer	0.000467	0.000532	CcSEcCtD
Pamidronate—Erythema—Doxorubicin—stomach cancer	0.000467	0.000532	CcSEcCtD
Pamidronate—Anaemia—Epirubicin—stomach cancer	0.000467	0.000531	CcSEcCtD
Pamidronate—Agitation—Epirubicin—stomach cancer	0.000464	0.000528	CcSEcCtD
Pamidronate—Myalgia—Methotrexate—stomach cancer	0.000459	0.000523	CcSEcCtD
Pamidronate—Arthralgia—Methotrexate—stomach cancer	0.000459	0.000523	CcSEcCtD
Pamidronate—Tension—Doxorubicin—stomach cancer	0.000458	0.000522	CcSEcCtD
Pamidronate—Dysgeusia—Doxorubicin—stomach cancer	0.000458	0.000521	CcSEcCtD
Pamidronate—Malaise—Epirubicin—stomach cancer	0.000455	0.000518	CcSEcCtD
Pamidronate—Discomfort—Methotrexate—stomach cancer	0.000454	0.000517	CcSEcCtD
Pamidronate—Nervousness—Doxorubicin—stomach cancer	0.000454	0.000516	CcSEcCtD
Pamidronate—Syncope—Epirubicin—stomach cancer	0.000453	0.000515	CcSEcCtD
Pamidronate—Leukopenia—Epirubicin—stomach cancer	0.000452	0.000514	CcSEcCtD
Pamidronate—Back pain—Doxorubicin—stomach cancer	0.000452	0.000514	CcSEcCtD
Pamidronate—Hypersensitivity—Docetaxel—stomach cancer	0.00045	0.000512	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.00045	0.0147	CbGpPWpGaD
Pamidronate—Muscle spasms—Doxorubicin—stomach cancer	0.000449	0.000511	CcSEcCtD
Pamidronate—Confusional state—Methotrexate—stomach cancer	0.000444	0.000505	CcSEcCtD
Pamidronate—Loss of consciousness—Epirubicin—stomach cancer	0.000444	0.000505	CcSEcCtD
Pamidronate—Cough—Epirubicin—stomach cancer	0.000441	0.000502	CcSEcCtD
Pamidronate—Anaphylactic shock—Methotrexate—stomach cancer	0.00044	0.000501	CcSEcCtD
Pamidronate—Asthenia—Docetaxel—stomach cancer	0.000438	0.000499	CcSEcCtD
Pamidronate—Convulsion—Epirubicin—stomach cancer	0.000437	0.000498	CcSEcCtD
Pamidronate—Infection—Methotrexate—stomach cancer	0.000437	0.000498	CcSEcCtD
Pamidronate—FDPS—Metabolism—GMPR2—stomach cancer	0.000436	0.0142	CbGpPWpGaD
Pamidronate—Hypertension—Epirubicin—stomach cancer	0.000436	0.000496	CcSEcCtD
Pamidronate—Hypersensitivity—Capecitabine—stomach cancer	0.000436	0.000496	CcSEcCtD
Pamidronate—Ill-defined disorder—Doxorubicin—stomach cancer	0.000433	0.000493	CcSEcCtD
Pamidronate—Pruritus—Docetaxel—stomach cancer	0.000432	0.000492	CcSEcCtD
Pamidronate—Nervous system disorder—Methotrexate—stomach cancer	0.000432	0.000492	CcSEcCtD
Pamidronate—Anaemia—Doxorubicin—stomach cancer	0.000432	0.000492	CcSEcCtD
Pamidronate—Thrombocytopenia—Methotrexate—stomach cancer	0.000431	0.000491	CcSEcCtD
Pamidronate—Myalgia—Epirubicin—stomach cancer	0.00043	0.000489	CcSEcCtD
Pamidronate—Arthralgia—Epirubicin—stomach cancer	0.00043	0.000489	CcSEcCtD
Pamidronate—Agitation—Doxorubicin—stomach cancer	0.000429	0.000489	CcSEcCtD
Pamidronate—Anxiety—Epirubicin—stomach cancer	0.000428	0.000488	CcSEcCtD
Pamidronate—Hyperhidrosis—Methotrexate—stomach cancer	0.000426	0.000485	CcSEcCtD
Pamidronate—Discomfort—Epirubicin—stomach cancer	0.000425	0.000483	CcSEcCtD
Pamidronate—Asthenia—Capecitabine—stomach cancer	0.000424	0.000483	CcSEcCtD
Pamidronate—Malaise—Doxorubicin—stomach cancer	0.000421	0.00048	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000421	0.0137	CbGpPWpGaD
Pamidronate—Anorexia—Methotrexate—stomach cancer	0.00042	0.000478	CcSEcCtD
Pamidronate—Syncope—Doxorubicin—stomach cancer	0.000419	0.000477	CcSEcCtD
Pamidronate—Pruritus—Capecitabine—stomach cancer	0.000419	0.000476	CcSEcCtD
Pamidronate—Leukopenia—Doxorubicin—stomach cancer	0.000418	0.000476	CcSEcCtD
Pamidronate—Diarrhoea—Docetaxel—stomach cancer	0.000418	0.000476	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000416	0.0136	CbGpPWpGaD
Pamidronate—Confusional state—Epirubicin—stomach cancer	0.000416	0.000473	CcSEcCtD
Pamidronate—Anaphylactic shock—Epirubicin—stomach cancer	0.000412	0.000469	CcSEcCtD
Pamidronate—Oedema—Epirubicin—stomach cancer	0.000412	0.000469	CcSEcCtD
Pamidronate—Hypotension—Methotrexate—stomach cancer	0.000411	0.000468	CcSEcCtD
Pamidronate—Loss of consciousness—Doxorubicin—stomach cancer	0.000411	0.000467	CcSEcCtD
Pamidronate—Infection—Epirubicin—stomach cancer	0.000409	0.000466	CcSEcCtD
Pamidronate—Cough—Doxorubicin—stomach cancer	0.000408	0.000464	CcSEcCtD
Pamidronate—Shock—Epirubicin—stomach cancer	0.000405	0.000461	CcSEcCtD
Pamidronate—Convulsion—Doxorubicin—stomach cancer	0.000405	0.000461	CcSEcCtD
Pamidronate—Diarrhoea—Capecitabine—stomach cancer	0.000405	0.000461	CcSEcCtD
Pamidronate—Nervous system disorder—Epirubicin—stomach cancer	0.000404	0.00046	CcSEcCtD
Pamidronate—Dizziness—Docetaxel—stomach cancer	0.000404	0.00046	CcSEcCtD
Pamidronate—Thrombocytopenia—Epirubicin—stomach cancer	0.000403	0.000459	CcSEcCtD
Pamidronate—Hypertension—Doxorubicin—stomach cancer	0.000403	0.000459	CcSEcCtD
Pamidronate—Tachycardia—Epirubicin—stomach cancer	0.000402	0.000458	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000401	0.000457	CcSEcCtD
Pamidronate—FDPS—Metabolism—IDH3B—stomach cancer	0.000399	0.013	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SUCLG1—stomach cancer	0.000399	0.013	CbGpPWpGaD
Pamidronate—Hyperhidrosis—Epirubicin—stomach cancer	0.000398	0.000453	CcSEcCtD
Pamidronate—Insomnia—Methotrexate—stomach cancer	0.000398	0.000453	CcSEcCtD
Pamidronate—Arthralgia—Doxorubicin—stomach cancer	0.000398	0.000453	CcSEcCtD
Pamidronate—Myalgia—Doxorubicin—stomach cancer	0.000398	0.000453	CcSEcCtD
Pamidronate—Anxiety—Doxorubicin—stomach cancer	0.000396	0.000451	CcSEcCtD
Pamidronate—Paraesthesia—Methotrexate—stomach cancer	0.000395	0.00045	CcSEcCtD
Pamidronate—Discomfort—Doxorubicin—stomach cancer	0.000393	0.000447	CcSEcCtD
Pamidronate—Anorexia—Epirubicin—stomach cancer	0.000393	0.000447	CcSEcCtD
Pamidronate—Dyspnoea—Methotrexate—stomach cancer	0.000393	0.000447	CcSEcCtD
Pamidronate—Somnolence—Methotrexate—stomach cancer	0.000391	0.000446	CcSEcCtD
Pamidronate—Dizziness—Capecitabine—stomach cancer	0.000391	0.000445	CcSEcCtD
Pamidronate—Vomiting—Docetaxel—stomach cancer	0.000388	0.000442	CcSEcCtD
Pamidronate—Dyspepsia—Methotrexate—stomach cancer	0.000388	0.000441	CcSEcCtD
Pamidronate—Rash—Docetaxel—stomach cancer	0.000385	0.000438	CcSEcCtD
Pamidronate—Hypotension—Epirubicin—stomach cancer	0.000385	0.000438	CcSEcCtD
Pamidronate—Dermatitis—Docetaxel—stomach cancer	0.000385	0.000438	CcSEcCtD
Pamidronate—Confusional state—Doxorubicin—stomach cancer	0.000384	0.000438	CcSEcCtD
Pamidronate—Decreased appetite—Methotrexate—stomach cancer	0.000383	0.000436	CcSEcCtD
Pamidronate—Headache—Docetaxel—stomach cancer	0.000383	0.000436	CcSEcCtD
Pamidronate—Oedema—Doxorubicin—stomach cancer	0.000381	0.000434	CcSEcCtD
Pamidronate—Anaphylactic shock—Doxorubicin—stomach cancer	0.000381	0.000434	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00038	0.000433	CcSEcCtD
Pamidronate—Fatigue—Methotrexate—stomach cancer	0.00038	0.000432	CcSEcCtD
Pamidronate—Infection—Doxorubicin—stomach cancer	0.000379	0.000431	CcSEcCtD
Pamidronate—FDPS—SREBP signalling—PIK3CA—stomach cancer	0.000377	0.0123	CbGpPWpGaD
Pamidronate—Pain—Methotrexate—stomach cancer	0.000377	0.000429	CcSEcCtD
Pamidronate—Vomiting—Capecitabine—stomach cancer	0.000376	0.000428	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000375	0.000427	CcSEcCtD
Pamidronate—Shock—Doxorubicin—stomach cancer	0.000375	0.000427	CcSEcCtD
Pamidronate—Nervous system disorder—Doxorubicin—stomach cancer	0.000374	0.000426	CcSEcCtD
Pamidronate—Thrombocytopenia—Doxorubicin—stomach cancer	0.000373	0.000425	CcSEcCtD
Pamidronate—Rash—Capecitabine—stomach cancer	0.000373	0.000425	CcSEcCtD
Pamidronate—Insomnia—Epirubicin—stomach cancer	0.000373	0.000424	CcSEcCtD
Pamidronate—Dermatitis—Capecitabine—stomach cancer	0.000373	0.000424	CcSEcCtD
Pamidronate—Tachycardia—Doxorubicin—stomach cancer	0.000372	0.000424	CcSEcCtD
Pamidronate—FDPS—Metabolism—NDUFV1—stomach cancer	0.000371	0.0121	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NDUFS1—stomach cancer	0.000371	0.0121	CbGpPWpGaD
Pamidronate—Headache—Capecitabine—stomach cancer	0.000371	0.000422	CcSEcCtD
Pamidronate—Paraesthesia—Epirubicin—stomach cancer	0.00037	0.000421	CcSEcCtD
Pamidronate—Hyperhidrosis—Doxorubicin—stomach cancer	0.000369	0.00042	CcSEcCtD
Pamidronate—Dyspnoea—Epirubicin—stomach cancer	0.000367	0.000418	CcSEcCtD
Pamidronate—Somnolence—Epirubicin—stomach cancer	0.000366	0.000417	CcSEcCtD
Pamidronate—Anorexia—Doxorubicin—stomach cancer	0.000363	0.000414	CcSEcCtD
Pamidronate—Nausea—Docetaxel—stomach cancer	0.000363	0.000413	CcSEcCtD
Pamidronate—Feeling abnormal—Methotrexate—stomach cancer	0.000363	0.000413	CcSEcCtD
Pamidronate—Dyspepsia—Epirubicin—stomach cancer	0.000363	0.000413	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000363	0.0118	CbGpPWpGaD
Pamidronate—Gastrointestinal pain—Methotrexate—stomach cancer	0.00036	0.00041	CcSEcCtD
Pamidronate—Decreased appetite—Epirubicin—stomach cancer	0.000358	0.000408	CcSEcCtD
Pamidronate—Hypotension—Doxorubicin—stomach cancer	0.000356	0.000406	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000356	0.000405	CcSEcCtD
Pamidronate—Fatigue—Epirubicin—stomach cancer	0.000355	0.000404	CcSEcCtD
Pamidronate—Pain—Epirubicin—stomach cancer	0.000352	0.000401	CcSEcCtD
Pamidronate—Constipation—Epirubicin—stomach cancer	0.000352	0.000401	CcSEcCtD
Pamidronate—Nausea—Capecitabine—stomach cancer	0.000351	0.0004	CcSEcCtD
Pamidronate—Abdominal pain—Methotrexate—stomach cancer	0.000348	0.000396	CcSEcCtD
Pamidronate—Body temperature increased—Methotrexate—stomach cancer	0.000348	0.000396	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000347	0.000395	CcSEcCtD
Pamidronate—Insomnia—Doxorubicin—stomach cancer	0.000345	0.000393	CcSEcCtD
Pamidronate—Paraesthesia—Doxorubicin—stomach cancer	0.000342	0.00039	CcSEcCtD
Pamidronate—Dyspnoea—Doxorubicin—stomach cancer	0.00034	0.000387	CcSEcCtD
Pamidronate—Feeling abnormal—Epirubicin—stomach cancer	0.00034	0.000387	CcSEcCtD
Pamidronate—Somnolence—Doxorubicin—stomach cancer	0.000339	0.000386	CcSEcCtD
Pamidronate—Gastrointestinal pain—Epirubicin—stomach cancer	0.000337	0.000384	CcSEcCtD
Pamidronate—Dyspepsia—Doxorubicin—stomach cancer	0.000336	0.000382	CcSEcCtD
Pamidronate—Decreased appetite—Doxorubicin—stomach cancer	0.000331	0.000377	CcSEcCtD
Pamidronate—FDPS—Metabolism—BLVRB—stomach cancer	0.000331	0.0108	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PGLS—stomach cancer	0.000331	0.0108	CbGpPWpGaD
Pamidronate—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000329	0.000375	CcSEcCtD
Pamidronate—Fatigue—Doxorubicin—stomach cancer	0.000329	0.000374	CcSEcCtD
Pamidronate—Constipation—Doxorubicin—stomach cancer	0.000326	0.000371	CcSEcCtD
Pamidronate—Pain—Doxorubicin—stomach cancer	0.000326	0.000371	CcSEcCtD
Pamidronate—Abdominal pain—Epirubicin—stomach cancer	0.000326	0.000371	CcSEcCtD
Pamidronate—Body temperature increased—Epirubicin—stomach cancer	0.000326	0.000371	CcSEcCtD
Pamidronate—Hypersensitivity—Methotrexate—stomach cancer	0.000324	0.000369	CcSEcCtD
Pamidronate—Asthenia—Methotrexate—stomach cancer	0.000316	0.00036	CcSEcCtD
Pamidronate—FDPS—Metabolism—PPAP2A—stomach cancer	0.000315	0.0103	CbGpPWpGaD
Pamidronate—Feeling abnormal—Doxorubicin—stomach cancer	0.000314	0.000358	CcSEcCtD
Pamidronate—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000312	0.000355	CcSEcCtD
Pamidronate—Pruritus—Methotrexate—stomach cancer	0.000312	0.000355	CcSEcCtD
Pamidronate—Hypersensitivity—Epirubicin—stomach cancer	0.000304	0.000346	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.000303	0.0099	CbGpPWpGaD
Pamidronate—Body temperature increased—Doxorubicin—stomach cancer	0.000301	0.000343	CcSEcCtD
Pamidronate—Abdominal pain—Doxorubicin—stomach cancer	0.000301	0.000343	CcSEcCtD
Pamidronate—Diarrhoea—Methotrexate—stomach cancer	0.000301	0.000343	CcSEcCtD
Pamidronate—Asthenia—Epirubicin—stomach cancer	0.000296	0.000337	CcSEcCtD
Pamidronate—Pruritus—Epirubicin—stomach cancer	0.000292	0.000332	CcSEcCtD
Pamidronate—Dizziness—Methotrexate—stomach cancer	0.000291	0.000331	CcSEcCtD
Pamidronate—Diarrhoea—Epirubicin—stomach cancer	0.000282	0.000321	CcSEcCtD
Pamidronate—FDPS—Metabolism—NDUFA2—stomach cancer	0.000281	0.00917	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—FBP1—stomach cancer	0.000281	0.00917	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CA1—stomach cancer	0.000281	0.00917	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CKB—stomach cancer	0.000281	0.00917	CbGpPWpGaD
Pamidronate—Hypersensitivity—Doxorubicin—stomach cancer	0.000281	0.00032	CcSEcCtD
Pamidronate—Vomiting—Methotrexate—stomach cancer	0.00028	0.000319	CcSEcCtD
Pamidronate—Rash—Methotrexate—stomach cancer	0.000278	0.000316	CcSEcCtD
Pamidronate—Dermatitis—Methotrexate—stomach cancer	0.000277	0.000316	CcSEcCtD
Pamidronate—Headache—Methotrexate—stomach cancer	0.000276	0.000314	CcSEcCtD
Pamidronate—Asthenia—Doxorubicin—stomach cancer	0.000274	0.000311	CcSEcCtD
Pamidronate—Dizziness—Epirubicin—stomach cancer	0.000273	0.00031	CcSEcCtD
Pamidronate—Pruritus—Doxorubicin—stomach cancer	0.00027	0.000307	CcSEcCtD
Pamidronate—FDPS—Metabolism—PLIN2—stomach cancer	0.000264	0.00862	CbGpPWpGaD
Pamidronate—Vomiting—Epirubicin—stomach cancer	0.000262	0.000298	CcSEcCtD
Pamidronate—Nausea—Methotrexate—stomach cancer	0.000262	0.000298	CcSEcCtD
Pamidronate—Diarrhoea—Doxorubicin—stomach cancer	0.000261	0.000297	CcSEcCtD
Pamidronate—Rash—Epirubicin—stomach cancer	0.00026	0.000296	CcSEcCtD
Pamidronate—Dermatitis—Epirubicin—stomach cancer	0.00026	0.000295	CcSEcCtD
Pamidronate—Headache—Epirubicin—stomach cancer	0.000258	0.000294	CcSEcCtD
Pamidronate—FDPS—Metabolism—CA2—stomach cancer	0.000257	0.00839	CbGpPWpGaD
Pamidronate—Dizziness—Doxorubicin—stomach cancer	0.000252	0.000287	CcSEcCtD
Pamidronate—FDPS—Metabolism—PGAM1—stomach cancer	0.000251	0.00818	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NT5E—stomach cancer	0.000251	0.00818	CbGpPWpGaD
Pamidronate—Nausea—Epirubicin—stomach cancer	0.000245	0.000279	CcSEcCtD
Pamidronate—Vomiting—Doxorubicin—stomach cancer	0.000242	0.000276	CcSEcCtD
Pamidronate—Rash—Doxorubicin—stomach cancer	0.00024	0.000274	CcSEcCtD
Pamidronate—Dermatitis—Doxorubicin—stomach cancer	0.00024	0.000273	CcSEcCtD
Pamidronate—FDPS—Metabolism—ALDH7A1—stomach cancer	0.000239	0.0078	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PLCE1—stomach cancer	0.000239	0.0078	CbGpPWpGaD
Pamidronate—Headache—Doxorubicin—stomach cancer	0.000239	0.000272	CcSEcCtD
Pamidronate—FDPS—Metabolism—UMPS—stomach cancer	0.000229	0.00748	CbGpPWpGaD
Pamidronate—Nausea—Doxorubicin—stomach cancer	0.000226	0.000258	CcSEcCtD
Pamidronate—FDPS—Metabolism—PDHA1—stomach cancer	0.000213	0.00695	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ECHS1—stomach cancer	0.000213	0.00695	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—TYMP—stomach cancer	0.0002	0.00654	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—FADS1—stomach cancer	0.0002	0.00654	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SREBF2—stomach cancer	0.000188	0.00612	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—RORA—stomach cancer	0.000185	0.00605	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ALDOB—stomach cancer	0.000174	0.00567	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	0.000164	0.00534	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	0.000163	0.00533	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ALOX5—stomach cancer	0.000161	0.00527	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—DPYD—stomach cancer	0.000159	0.00518	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	0.000144	0.0047	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTT1—stomach cancer	0.00014	0.00458	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP2A6—stomach cancer	0.000139	0.00453	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—AKR1C3—stomach cancer	0.000135	0.00441	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ENO1—stomach cancer	0.000132	0.00429	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ALB—stomach cancer	0.000129	0.00422	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CD44—stomach cancer	0.000117	0.00381	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	0.000113	0.0037	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PPP2R1A—stomach cancer	9.93e-05	0.00324	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTP1—stomach cancer	9.74e-05	0.00318	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—HMOX1—stomach cancer	9.6e-05	0.00313	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—TYMS—stomach cancer	9.05e-05	0.00295	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTM1—stomach cancer	8.95e-05	0.00292	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ERCC2—stomach cancer	8.41e-05	0.00274	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—MTHFR—stomach cancer	7.91e-05	0.00258	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CAV1—stomach cancer	7.29e-05	0.00238	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—APOA1—stomach cancer	7.28e-05	0.00237	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.97e-05	0.00227	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PPARG—stomach cancer	6.41e-05	0.00209	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ALB—stomach cancer	5.77e-05	0.00188	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NOS3—stomach cancer	5.51e-05	0.0018	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PTGS2—stomach cancer	5.04e-05	0.00165	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PIK3CA—stomach cancer	3.1e-05	0.00101	CbGpPWpGaD
